CT Assessment of BMI in Endometrial Cancer Patients
NCT03962140 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 302
Last updated 2021-09-16
Summary
This study is a retrospective study to investigate the association between body fat distribution and sarcopenia on CT-scan and oncological outcomes in endometrial cancer patients
Conditions
Sponsors & Collaborators
-
Royal Cornwall Hospitals Trust
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-08-01
- Primary Completion
- 2021-03-01
- Completion
- 2021-03-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Specimen PET-CT Imaging for Intraoperative Margin Assessment in Breast Cancer
NCT04999917 ·Status: COMPLETED ·Phase: NA
-
Evaluation of OE-MRI in Patients With H&N Cancer
NCT04724096 ·Status: COMPLETED
-
Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer
NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Usefulness of 18F-FDG PET/CT in the Initial Staging and Surveillance of Endometrial Cancer Patients
NCT05056259 ·Status: UNKNOWN
-
PET/CT and Sentinel Node in Oral Cancer
NCT01136265 ·Status: UNKNOWN
-
Clinical Application of 68Ga-FAPI PET Imaging in Detection of Ovarian Cancer Recurrence
NCT05856409 ·Status: RECRUITING
-
A Novel Functional Imaging Technique With FLT-PET/MRI For Staging, Response Assessment and Radiation Treatment Planning in Cervix Cancer
NCT05355558 ·Status: UNKNOWN ·Phase: NA
-
Benchmarking Intra-tumor Heterogeneity In Ovarian Cancer: Linking In-vivo Imaging Phenotypes With Histology And Genomics
NCT02144311 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of 18F-FAPI-RGD in Ovarian Cancer
NCT06614062 ·Status: COMPLETED
-
The Prognostic Value of FDG PET/CT and Diffusion-weighed Imaging on Breast Cancer
NCT01942759 ·Status: COMPLETED
-
Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer
NCT02765698 ·Status: TERMINATED
-
18F-LN1 PET/CT in Urothelial Carcinomas
NCT06120413 ·Status: RECRUITING
-
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
NCT00904410 ·Status: COMPLETED ·Phase: PHASE4
-
Intra-operative PET-CT: a Novel Approach to Determine Excision Margins in Lumpectomy Breast Cancer.
NCT04343079 ·Status: RECRUITING ·Phase: NA
-
Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study
NCT04316117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET
NCT05889312 ·Status: RECRUITING
-
Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer
NCT07285564 ·Status: RECRUITING ·Phase: NA
-
Energy CT in Imaging and Diagnosis of Gastric Cancer
NCT06869694 ·Status: RECRUITING
-
68Ga-FAPI-04 and 18F-FDG PET/CT in Patients With Epithelial Ovarian Cancer: Compared With Histological Findings
NCT04504110 ·Status: UNKNOWN ·Phase: PHASE2
-
A Prospective Cohort Study of 68ga-FAPI-pet-ct Versus FDG-pet-ct for Ovarian Cancer
NCT05824247 ·Status: UNKNOWN
-
Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy
NCT01269970 ·Status: COMPLETED
-
Prediction of 18F-FES-PET/CT Parameters on Palbociclib Combined With ET
NCT04992156 ·Status: COMPLETED
-
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
NCT05681234 ·Status: COMPLETED ·Phase: NA
-
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
NCT00592462 ·Status: COMPLETED
-
FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer
NCT02995902 ·Status: COMPLETED ·Phase: NA